Edwards Lifesciences (EW) Tops Q3 EPS by 9c, Q4 & FY Guidance Tops Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Canaccord Genuity Reiterates Buy on Edwards Lifesciences (EW) following 3Q Results
October 27, 2015 10:50 AM EDTCanaccord Genuity reiterated a Buy rating on Edwards Lifesciences (NYSE: EW), and raised the price target to $180.00 (from $178.00), following the company's 3Q earnings results. EW reported EPS of $1.07, beating consensus by 9c. Management does an excellent job hedging FX swings to neutralize EPS... More
UBS Raises Price Target on Edwards Lifesciences (EW) Following Strong 3Q Results
October 27, 2015 8:57 AM EDTUBS reiterated a Buy rating on Edwards Lifesciences (NYSE: EW), and raised the price target to $203.00 (from $201.00), following the company's 3Q15 earnings results. Management upped fullyear EPS guidance by $4.43-4.53 from $4.30-4.40, which assumes a touch more upside in Q4.
Analyst Matt Miksic... More
